Impact of Nirsevimab on Admission to a Spanish Pediatric Intensive Care Unit Because of RSV Bronchiolitis: Unicentric Observational Study from 2017 to 2024
- Ana Espeleta-Fox; Alberto García-Salido; Almudena Vallespín-Casas; Inés Leoz-Gordillo; José Unzueta-Roch; Gema De Lama Caro-Patón
Access Resources
About
This letter describes admissions to a pediatric critical care unit (PICU) because of acute bronchiolitis caused by respiratory syncytial virus. The study looked at a single children's hospital in Spain from 2017 to 2024. Groups of infected children were compared, including those who had received nirsevimab and those who had not.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.